This new podcast series explores real world research, its value, and enterprise perspectives on the topic. If you are deploying digital health solutions running pilots, generating real world outcomes, or tracking what works and what doesn't, you may find this series of particular interest. If work lives only in internal dashboards and slide decks, it's invisible to the clinicians,
payers, regulators, and partners who need it most - those creating, building, developing solutions that transform real world practice and clinical applications.
Whether you work in pharma, a health plan, a digital health startup, or a health system—this will explain why publishing is now a strategic imperative, not just an academic exercise.
Listen now at DOI: https://doi.org/10.30953/thmt.v11.709
Whether you work in pharma, a health plan, a digital health startup, or a health system—this will explain why publishing is now a strategic imperative,
not just an academic exercise.
Regulators, payers, and health systems are demanding proof. Coverage decisions, partnership deals, and procurement conversations increasingly hinge on published evidence.
WHAT YOU'LL LEARN
- What types of enterprise work qualify as publishable research (more than
you think)
- Why THMT is built for real world, practitioner led evidence—not just academic studies
- How pharma, payers, and startups each benefit from publishing
- How to overcome the most common barriers: time, legal concerns, and "we're not academics"
- What editors
are actively looking for right now—and how to get started
